Neuromeka Announces First Issue Price of 38,350 Won for 25.76% Rights Offering, Raising Concerns of Shareholder Dilution

Neuromeka has finalized the first issue price at 38,350 won for its rights offering of 3,196,465 shares, representing a massive dilution of approximately 25.76% relative to its outstanding shares of 12,409,151.
The first issue price reflects a 20% discount from the base price and is about 21% below the current market price of 48,600 won, unfavorable to existing shareholders. The final issue price will be determined after the second issue price is calculated.
The purpose of the capital raise has not been disclosed, creating uncertainty about fund usage. The large dilution and discounted pricing are likely to exert downward pressure on the stock price in the near term.
[AI Summary]Neuromeka's 25.76% rights offering severely dilutes existing shareholder value, and the discounted issue price adds downward pressure on the stock. The undisclosed use of proceeds undermines investor confidence, leading to expected short-term price weakness.